Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New pelotte device aims to improve temperature accuracy in cancer heat therapy

NCT ID NCT07235540

First seen Nov 19, 2025 · Last updated Jun 23, 2026 · Updated 38 times

Summary

This study tests whether a new device called a pelotte can measure vaginal temperature more accurately during deep hyperthermia (heat therapy) for gynecologic cancer. Twenty-seven women receiving radiation plus heat therapy will have their temperature measured with both the pelotte and a standard probe across multiple treatments. The goal is to see if the pelotte gives more consistent and reliable readings, which could help improve treatment precision.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GYNAECOLOGIC CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Erasmus MC

    Rotterdam, South Holand, 3015GD, Netherlands

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

pelotte (a PTFE rod with a temperature catheter, covered by a condom)

What this could lead to

If successful, this could lead to more accurate temperature measurements during hyperthermia treatment, potentially improving treatment effectiveness for gynecologic cancer.

What could go wrong

This is a small, early-stage study (27 participants) focused on measurement accuracy, not treatment outcomes. The device may not improve clinical results or patient comfort.

Conditions

The condition(s) this trial relates to.

female reproductive organ cancer Hyperthermia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.